VDRM — Viaderma Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.25m
- $4.97m
- $0.45m
Annual income statement for Viaderma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | 2011 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 25.3 | 26.8 | 19 | 0.601 | 0.451 |
| Cost of Revenue | |||||
| Gross Profit | 11 | 10.1 | 5.66 | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 18.9 | 19.1 | 15 | 0.52 | 1.32 |
| Operating Profit | 6.39 | 7.77 | 4.04 | 0.081 | -0.869 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 6.07 | 6.5 | 3.55 | 0.004 | -3.87 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.09 | 4.51 | 2.67 | 0.004 | -3.87 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.09 | 4.51 | 2.67 | 0.004 | -3.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 4.09 | 4.51 | 2.67 | 0.004 | -3.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 29.6 | 32.8 | 19.5 | 0 | -0.003 |
| Dividends per Share |